Endogenex

DyaMX is an early stage medical device company focused on the treatment of Type 2 Diabetes.

HQ location

Minneapolis, United States

Website

Launch date

2017

Employees

Enterprise value

$352—528m

https://www.linkedin.com/company/endogenexinc/

Get premium to view all results

Date	Investors	Amount	Round
-	investor investor	€0.0	round
Feb 2018	N/A	€0.0	round
Dec 2018	N/A	€0.0	round
Apr 2021	N/A	€0.0	round
Jun 2024*	Hatteras Venture Partners Sante Ventures Mayo Clinic Longitude Capital Lumira Ventures Intuitive Ventures Orlando Health Ventures	$88.0m	Series C
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads